Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective tone conveys that the study challenges conventional use of hydrochlorothiazide for kidney stone prevention, with words like 'little efficacy' and 'not effective' highlighting a dismissive tone, while some comments express surprise about the results, illustrating a slight shift in the perceived impact of the medication in clinical practice.
Most discussions acknowledge that the study found hydrochlorothiazide ineffective for preventing recurrent kidney stones, reflecting a consensus that the evidence challenges previous beliefs about its benefits.
The discussions show moderate curiosity, with some participants questioning current practices, but overall, the focus remains on the study's implications rather than deep exploration or enthusiasm.
Many discussions are brief, referencing the study or summarizing outcomes without extensive analysis, indicating a relatively low level of deep engagement with the intricacies of the research.
Given the multiple mentions of practice change and guideline reconsideration, but without significant controversy or alternative perspectives, the perceived impact appears modest.
Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
Hey urology twitter - are y'all dropping HCTZ from your practice? Are the guidelines changing? Did I miss the discussion? https://t.co/gROUgqPQKf
Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15Fg3gV4 https://t.co/GC3Rq7pBPM
Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
Do you live in the Stone Belt ? How often do you encounter a recurrent kidney stone former? Join us tonight at 9 PM IST for the second chat of #nephJC on the NO STONE trial . NEPHROCIOUS (POD 4) NSMC 2023 is excited to host you https://t.co/ROW1EyZa20 #NephJC https://t.co/J3QybzoTtX
Prof Daniel Fuster and PrivDoz Sven Trelle discuss evidence-based therapies for secondary prevention of calcium-based kidney stones, highlighting the NOSTONE study on hydrochlorothiazide return prevention and dietary…
This video discusses current trends in prostate cancer screening, including the effectiveness of PSA testing and new technologies. It also covers the latest research on preventing kidney-stone recurrence with…
@paulelarzy @Topiramatee Le niveau de preuve est pas genialissime (dernier RCT que j'ai en tête : https://t.co/9uv2D9odYa), les thiazidiques font pisser du sodium (pas bon pour la maladie lithiasique), exposent à toutes les toxicités de ces médicaments...
@MartyMakary would LOVE your take on this study (I’m reading Blind Spots now). I challenged my urologist with the results since I’ve been taking HCTZ for years. The practice won’t budge… but of course I can do what I want
In light of NOSTONE, NCT03057431 trial results https://t.co/JFYoaH6bzK
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | New England Journal of Medicine https://t.co/zCUgqe8M9S
RT @com_SFNDT:
@HeerspinkHiddo @DavidCWheeler2 @EWijkmark @MagnusAstrand @GreaserPete @BradRovin @IgAN_JBarratt 4: NOSTONE from Nasser A. Dhayat, Sven Trulle and @Dan_Fuster from the @inselgruppe @unibern Detailed talk at https://t.co/dqhrEEbxN3 (
RT @georgepapadapol: Hidrocloritiazida (HCT) y recurrencia) de cálculos renales No se encontró relación entre las dosis de HCT y recurrenci…
Hidrocloritiazida (HCT) y recurrencia) de cálculos renales No se encontró relación entre las dosis de HCT y recurrencia sintomática/radiológica de cálculos, pero hubo exceso de eventos adversos (diabetes mellitus de novo, hipokalemia, Gota y alergia)
RT @uppghnephrology:
RT @ralcazara: Siempre nos quedará el agua......La hidroclorotiazida no reduce la recurrencia de litiasis renal. En @NEJM https://t.co/todN…
RT @ralcazara: Siempre nos quedará el agua......La hidroclorotiazida no reduce la recurrencia de litiasis renal. En @NEJM https://t.co/todN…
RT @ralcazara: Siempre nos quedará el agua......La hidroclorotiazida no reduce la recurrencia de litiasis renal. En @NEJM https://t.co/todN…
RT @ralcazara: Siempre nos quedará el agua......La hidroclorotiazida no reduce la recurrencia de litiasis renal. En @NEJM https://t.co/todN…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial - Kidney Medicine https://t.co/QiMuoZk731
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
RT @KidneyMed: Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15F…
Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial https://t.co/nt15Fg3gV4 https://t.co/GC3Rq7pBPM
RT @nsmithmd: Felt smart earlier today answering a @UWorldMedical question right about HCTZ and kidney stones. Then I saw this bad boy come…
R's doctor showed him a recent paper from NJEM (relevant to R's medical history) & they geeked out over p-levels together: https://t.co/TJ3dOksPVm.
腎結石予防で日本の結石ガイドライン2013（古い！）にもあるサイアザイド系利尿薬、NEJMのRCTで否定されてて涙目
RT @JonathanNefro: Con historia de >2 litiasis por calcio, 59% tuvo recurrencia en 3 años, la hidroclorotiazida en diferentes dosis, compar…
4/ The #NOSTONE trial was a Swiss multicenter RCT aimed to evaluate the efficacy of #hydrochlorothiazide (HCTZ) in preventing the recurrence of nephrolithiasis in high-risk patients. https://t.co/uGwCao6EPs
Ryan S Hsi: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/kv7cTHaOSe
Ryan S Hsi: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/kv7cTHaOSe
Great questions that we tried to answer ! Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/D9qL7uOIvR
Ryan S Hsi: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/kv7cTHaOSe
Thanks to Dr. Fong (2nd year fellow) for lively JC debate on thiazides for stones. Still room to use these meds it seems. Need to consieder pharmacokinetics of drugs and K balance! Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/eb55sQDT3m
https://t.co/GqVhhxFTHZ Great discussion on kidney stone prevention and NOSTONE with Gunnar, Marcus and Sven ! Thank you Marcus@home for hosting us.
RT @gunnar_heine: Ab morgen bei #MARKUSatHOMe: STEINHARTE EVIDENZ zur Nephrolithiasis: Prof. Daniel Fuster und PD Sven Trelle von der @ins…
RT @gunnar_heine: Ab morgen bei #MARKUSatHOMe: STEINHARTE EVIDENZ zur Nephrolithiasis: Prof. Daniel Fuster und PD Sven Trelle von der @ins…
Ab morgen bei #MARKUSatHOMe: STEINHARTE EVIDENZ zur Nephrolithiasis: Prof. Daniel Fuster und PD Sven Trelle von der @inselgruppe @unibern Rezidiv-Prävention der Nephrolithiasis - NOSTONE - https://t.co/utpiS5qOXX via @YouTube mit @MarcusSaemann @oegnephro @dgfn_ev @com_SFNDT
RT @NephJC: 2/10 What did I miss? If someone has recurrent calcium stones we all know the drill - increase fluid intake, cut out NaCl, mod…
2/10 What did I miss? If someone has recurrent calcium stones we all know the drill - increase fluid intake, cut out NaCl, modify diet, add citrate, start a thiazide. Well, NOSTONE put that final piece of the algorithm to the test. https://t.co/ROW1EyZa20
RT @Renino20: Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
RT @Renino20: Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
RT @Renino20: Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
RT @Renino20: Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
RT @Renino20: Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
Recurrencia litiasis-hidroclorotiazida ECA NOSTONE n416
Though often prescribed, diuretic pills may not prevent kidney stones https://t.co/XUwB4lHdJi https://t.co/R7vlGmzKGx https://t.co/Z2QG3TgCZV
RT @NephJC: Do you live in the Stone Belt ? How often do you encounter a recurrent kidney stone former? Join us tonight at 9 PM IST for th…
Do you live in the Stone Belt ? How often do you encounter a recurrent kidney stone former? Join us tonight at 9 PM IST for the second chat of #nephJC on the NO STONE trial . NEPHROCIOUS (POD 4) NSMC 2023 is excited to host you https://t.co/ROW1EyZa20 #NephJC https://t.co/J3QybzoTtX
@jmteakell @NephJC @NSMCInternship @RenzPasilan And then copied the wrong link!! https://t.co/RpcItrrBOV
https://t.co/npYWp071cZ En conclusión poco podemos hacer...
10/10 Final thoughts ✳️ Waitlist journey can be daunting as it is, our patients don’t need more impediments when aren't really necessary ➡️Up next, Rolling Stone's new hit Hydrochlorothiazide couldn't give any satisfaction in preventing kidney stones https://t.co/ROW1EyZa20 https://t.co/zxpb3zta5P
尿路結石患者にサイアザイド投与による(尿中Ca排泄抑制に伴う)予防効果はあるか？ ー＞400人を３年観察。再発予防効果なし。 NEJM 2023 https://t.co/BMlvwfOOxv
RT @NephJC: Looking forward to the next NephJC discussion for the NOSTONE trial in 2 weeks https://t.co/ROW1EyZa20 #NephJC https://t.co/JPC…
RT @NephJC: Looking forward to the next NephJC discussion for the NOSTONE trial in 2 weeks https://t.co/ROW1EyZa20 #NephJC https://t.co/JPC…
Looking forward to the next NephJC discussion for the NOSTONE trial in 2 weeks https://t.co/ROW1EyZa20 #NephJC https://t.co/JPCAkPPIfW
@Baine_H @OddieMS @YuUrology @Braxton_uro @jasonkweiss @WJBrockway @zainhydermd @marawaneltayeb @patslowry @J_W_Lucas @bludvl @KristoferWagner @LesterPWangMD https://t.co/GsP9HcmEOV
Hey urology twitter - are y'all dropping HCTZ from your practice? Are the guidelines changing? Did I miss the discussion? https://t.co/gROUgqPQKf
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/wDgj7PYciT
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
https://t.co/bXUZUSKYER #emergency #medicine #em #erlife #emergencymedicine #doctor #data #Science #research #nejm #journal #cure #medtwitter #foamed
#Hydrochlorothiazide and Prevention of #Kidney-Stone Recurrence For more: https://t.co/pEJ3s36ppb
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/66BY18zDM5
Hidroclorotiazida y prevención de la recurrencia de cálculos renales https://t.co/dVA4Xss3db La incidencia de recurrencia no pareció diferir sustancialmente entre los pacientes que recibieron hidroclorotiazida 1 vez al día en dosis de 12,5 mg, 25 mg o 50 mg o placebo 1 vez al día
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/X1lGKrneUX
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/UcC0h2dn2r
RT @XBayona:
RT @RobCalvert18: NEJM study shows no benefits of giving thiazides to unselected recurrent calcium stone formers. Perhaps targeting those…
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
NEJM study shows no benefits of giving thiazides to unselected recurrent calcium stone formers. Perhaps targeting those with hypercalciuria refractory to dietary sodium correction might have revealed a statistically significant relative risk reduction. https://t.co/OBS4dMT3Ab https://t.co/mWPgZqKzEh
RT @NephRodby: NEJM says " the incidence of recurrence did not appear to differ substantially among pts receiving HCTZ... once daily. See #…
NEJM says " the incidence of recurrence did not appear to differ substantially among pts receiving HCTZ... once daily. See #ASNCommunities for excellent discussion https://t.co/sSl34sdU3b https://t.co/nJxJ82A9Jc
For the full article
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM 追跡期間2.9年 過去のRCTや観察研究の結果から少なくとも追跡期間は3-5年必要なのではないか？ 時代背景，患者背景が異なるため直接比較はできないが https://t.co/t1fAkH8Pdt
RT @LeslieMegom:
RT @Urologeman:
RT @Urologeman:
RT @Urologeman:
Un petit échantillon mais un essai qui remet en question la place des thiazidiques dans le risque de récidive des calculs rénaux calciques : pas d'efficacité et des effets indésirables dans ce travail. Quel est l'avis des experts? @LucileFigueres https://t.co/2mipu99rEC
RT @Urologeman:
RT @Urologeman:
RT @Urologeman:
RT @Urologeman:
薬の投与量が最も多かった患者で49%でしたが偽薬群との有意差はありませんでした。ただし、本研究ではサイアザイド系利尿薬が有効な尿中カルシウム濃度が高い患者は1/3しか含まれておらず、投与量も通常の半分でした。https://t.co/BQa7bdZ3fQ
RT @marawaneltayeb: Join @CoREndourology Virtual Journal Club to discuss the most recent @NEJM Thiazides and kidney stone prevention articl…
RT @marawaneltayeb: Join @CoREndourology Virtual Journal Club to discuss the most recent @NEJM Thiazides and kidney stone prevention articl…
RT @marawaneltayeb: Join @CoREndourology Virtual Journal Club to discuss the most recent @NEJM Thiazides and kidney stone prevention articl…
RT @LeslieMegom:
Join @CoREndourology Virtual Journal Club to discuss the most recent @NEJM Thiazides and kidney stone prevention article #urology #KidneyDisease #endourology #UroSoMe https://t.co/dm9cClBRPp https://t.co/4HH7Srb1Vl
RT @rincondesisifo: (NEJM) Seguridad y eficacia de la hidroclorotiazida en la prevención de recaídas en pac con litiasis renal https://t.co…
Join to discuss the most recent @NEJM kidney stone prevention manuscript https://t.co/njLsLPhiUY
RCT | Hydrochlorothiazide is not effective for the prevention of kidney-stone recurrence – via @NEJM https://t.co/quDLig4Yn0 Video summary: https://t.co/ulrBwzP8cK Commentary: https://t.co/xtvFfdNqr5
Reference (https://t.co/182ZYLRPKL)
RT @DptMedecineCHUV: Une étude montre que le traitement préventif de récidive des calculs rénaux par hydrochlorothiazide est peu efficace.…
(NEJM) Seguridad y eficacia de la hidroclorotiazida en la prevención de recaídas en pac con litiasis renal https://t.co/PB0CbrhkOC ECA https://t.co/xEDhX2Or9m Vídeo resumen https://t.co/h0sVP4NeW1
RT @DptMedecineCHUV: Une étude montre que le traitement préventif de récidive des calculs rénaux par hydrochlorothiazide est peu efficace.…
RT @DptMedecineCHUV: Une étude montre que le traitement préventif de récidive des calculs rénaux par hydrochlorothiazide est peu efficace.…
The NOSTONE trial results - will this change our practice?Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/k8U2I9hNIB
Une étude montre que le traitement préventif de récidive des calculs rénaux par hydrochlorothiazide est peu efficace. Résultat d'une collaboration entre la #nephrologie et #urologie du CHUV et @inselgruppe, parue dans The New England Journal of Medicine: https://t.co/sq2TNkW7BJ https://t.co/8ny9bYA7ez
RT @alfonso_casi: En pacientes con cálculos renales recurrentes, la incidencia de recurrencia no pareció diferir sustancialmente entre los…
RT @alfonso_casi: En pacientes con cálculos renales recurrentes, la incidencia de recurrencia no pareció diferir sustancialmente entre los…
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
腎結石の再発予防に、ヒドロクロロチアジドの投与は、再発率に大きな差はない https://t.co/GTsgUMOg4i
En pacientes con cálculos renales recurrentes, la incidencia de recurrencia no pareció diferir sustancialmente entre los pacientes que recibieron hidroclorotiazida una vez al día en dosis de 12,5 mg, 25 mg o 50 mg o placebo una vez al día. https://t.co/t4FNDb6U6o
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/ZmaoS3nhZh
RT @pinacol: 【RCT】再発性カルシウム含有腎結石患者へのヒドロクロロチアジド12.5mg、25mgまたは50mgの投与は、プラセボの投与と比較して、症候性または放射線学的腎結石再発の複合を減少させなかった。 #ペ読 https://t.co/YKWnrQsHkL
RT @JonathanNefro: Con historia de >2 litiasis por calcio, 59% tuvo recurrencia en 3 años, la hidroclorotiazida en diferentes dosis, compar…
RT @LeslieMegom:
【RCT】再発性カルシウム含有腎結石患者へのヒドロクロロチアジド12.5mg、25mgまたは50mgの投与は、プラセボの投与と比較して、症候性または放射線学的腎結石再発の複合を減少させなかった。 #ペ読 https://t.co/YKWnrQsHkL
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/tuyYxBwtso
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @LeslieMegom:
Hydrochlorothiazide does not prevent kidney stone recurrence https://t.co/w6382ld7ql
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @XBayona:
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @brian_rifkin: Thiazides don’t change the incidence of recurrent kidney stones
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @LeslieMegom:
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/bhWbeRUrQT
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @NEJM: Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
Research Summary: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/9MNRQaX90o https://t.co/Om2u8GPSNl
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @vic_pallares: ⁉️#NOSTONEtrial, efficacy of thiazides in the prevention of the recurrence of kidney stones?⤵️
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
RT @ASPNeph: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/2rKLdUxeyw @NEJM https://t.co/5j8dGtUibB
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence | NEJM https://t.co/4tM91lWtxv
though. https://www.nejm.org/doi/full/10.1056/NEJMoa2209275?query=featured_home
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence https://t.co/cOoczie4Bn https://t.co/zyTbc6mO2F
doi:10.1056/NEJMoa2209275. Environ Res Public Health. 2022;20(1):74. doi:10.3390/ [2] Stamatelou K, Goldfarb DS. Epidemiology of kidney ijerph20010074 ...
doi:10.1056/ NEJMoa2209275 PMID:36856614. Diaz, P., Takele, R. A., Thaker, S., Thaker, K. N., Ballon, J., Lucas, M., Kunitsky, K., & Scotland, K. B. (2022) ...
doi:10.1056/ NEJMoa2209275. PMID:36856614 [2] yall, V. S., Wood, K. D., & Pais, V. M. Jr. (2023). Hydrochlorothiazide and Prevention of KidneyStone
org/doi/full/10.1056/NEJMoa2209275?query=WB&cid =NEJM+Weekend+Briefing%2C+March+4%2C+2023+ DM2086098_NEJM_Non_Subscriber&bid=1444340528 · Không có mô tả ảnh ...
org/doi/full/10.1056/NEJMoa2209275?query=WB&cid =NEJM+Weekend+Briefing%2C+March+4%2C+2023+ DM2086098_NEJM_Non_Subscriber&bid=1444340528. No photo description ...
Prevention of Kidney-Stone Recurrence. The New England Journal of Medicine, 388(9), 781–791. doi:10.1056/ NEJMoa2209275 PMID:36856614 [2] yall ...
doi: 10.1056/NEJMoa2209275 · No photo description available.
doi:10.1056/NEJMoa2209275; Vanderbilt University Medical Center. Higher thiazide doses shown to reduce kidney stone events. EurekAlert ...
2023;doi:10.1056/NEJMoa2209275. Kidney stones: Treatment and prevention. https://www.aafp.org/pubs/afp/issues/2019/0415/p490.html. Published ...
org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. また一つ、飲まなくて済む薬が増えたな......もしGLP-1 ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Ένα ακόμη φάρμακο που ΔΕΝ ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Yksi lääke vähemmän, mitä mun ei ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Încă un medicament pe care NU ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Satu lagi ubat yang AKU TAK PERLU ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Mais um medicamento que NÃO preciso ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Thêm một loại thuốc mình KHÔNG phải ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Еще одно лекарство, которое мне НЕ ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Un altro farmaco che NON devo ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Noch ein Medikament, das ich NICHT ...
嗯，我想我将停止服用HCTZ，因为最近的一项研究表明，它在预防复发性肾结石方面并不比安慰剂更好！ https://www.nejm.org/doi/full/10.1056/nejmoa2209275 ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Mais um medicamento que NÃO preciso ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Isa pang gamot na HINDI ko na ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. En medisin mindre jeg IKKE trenger ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Artık almam gereken bir ilaç daha ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. One more drug I do NOT have to take ...
https://www.nejm.org/doi/full/10.1056/nejmoa2209275#:~:text=Conclusions,mg%20or%20placebo%20once%20daily. Még egy gyógyszer, amit NEM kell ...
... 10.1056/NEJMoa2209275 ... 10.1056/NEJMoa2209275. Instagram. Log in · Open app · amboss_med_de's profile picture · amboss_med_de. •. Follow.
Autoren: Dhayat NA et al. ... Quelle: N Engl J Med 2023 Mar 2;388(9):781-791. Web: https://doi.org/10.1056/NEJMoa2209275.
doi: 10.1056/NEJMoa2209275. PMID: 36856614. 撰文：Frank 编辑：Luzy. 免责声明· 我要投稿. 氢氯噻嗪肾结石影像学剂量. 点赞 34. 打赏. 精彩评论.
doi: 10.1056/NEJMoa2209275. PMID: 36856614. 背景： 肾结石是影响肾脏的最常见疾病之一，其特征是复发风险高。噻嗪类利尿剂广泛用于预防肾结石复发 ...
... 10.1056/NEJMoa2209275. Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence. Nasser A Dhayat, Olivier Bonny, Beat Roth, Andreas ...
Hydrochlorothiazide and prevention of kidney-stone recurrence. N Engl J Med 2023; 388:781–791. doi: 10.1056/NEJMoa2209275].
... 10.1056/NEJMoa2209275) Patienten mit rezidivierten kalziumhaltigen Nierensteinen überraschenderweise nicht vor einem neuen Ereignis schützen ...
URL: https://www.nejm.org/doi/full/10.1056/NEJMoa2209275 DOI: 10.1056/NEJMoa2209275.
... 10.1056/NEJMoa2209275?query=WB&cid=NEJM+Weekend+Briefing%2C+March+4%2C+2023+DM2086098_NEJM_Non_Subscriber&bid=1444340528. Log in ·
10.1056/NEJMoa2209275. Copyright © 2023 HealthDay. All rights reserved. Citation: Though often prescribed, diuretic pills may not prevent ...
2023;doi:10.1056/NEJMoa2209275. Disclosures: Dhayat reports no relevant financial disclosures. Please see the study for all other authors ...
doi:10.1056/NEJMoa2209275. Alexander RT. Do thiazides reduce the risk of kidney-stone recurrence? N Engl J Med 388:841-842. Published online ...
doi:10.1056/NEJMoa2209275. Newsletter. Join thousands of clinicians staying current on new therapies, trial data, and expert insights ...
... ://www.nejm. org/doi/full/10.1056/NEJMoa2209275?query=feature d_home. Ming Hung Tsai and 57 others ·
... 10.1056/NEJMoa2209275?query=featured_home. Log in ·
Urindrivande behandling med tiaziden hydroklortiazid var inte bättre än placebo på att minska återfall av njurstenar, visar en randomiserad ...
... 10.1056/NEJMoa2209275. Secondary Source. New England Journal of ... Source Reference: Alexander TR "Do thiazides reduce the risk of kidney-stone ...
N
AU
KM
IB
UG
NC
I
秀佳
PF
DK
CV
S
HT
G
MM
UN
JN
D
JG
JJ
DD
DN
I
HA
DN
HF
LM
DR
WH
EP
RG
SR
FB
MJ
RP
A
DG
う
NL
YE
CB
DF
P
J
IG
J
MS
AC
AB
JM
MM
SP
あ
BR
JR
A
A
JD
T
S
TG
D
XB
MK
HU
K
RC
MH
RR
HM
猫
VH
EB
DU
KT
SR
FH
TS
A
RZ
サ
SB
KM
AM
I
MM
P
C
DC
PU
R
R
IG
NF
DC
JJ
JS
HD
幸
SJ
A
HQ
DF
TH
SM
JL
EA
P
TH
F
M
JL
DR
A
DN
JR
MM
SM
JH
R
RP
TM
AF
MR
MA
A
K
KL
با
EM
V
R
B
DW
YM
DC
AV
A
JC
ภณ
보
AB
PB
GV
ZM
DP
AM
B
BL
DU
TR
VB
JC
PM
C
AB
CF
DA
A
JD
JM
EJ
SS
GS
DO
D
E
DM
R